nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—CYP3A4—type 2 diabetes mellitus	0.125	0.505	CbGaD
Meloxicam—PTGS2—type 2 diabetes mellitus	0.122	0.495	CbGaD
Meloxicam—ABCC4—Nateglinide—type 2 diabetes mellitus	0.0466	0.0928	CbGbCtD
Meloxicam—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.0305	0.0608	CbGbCtD
Meloxicam—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.0305	0.0608	CbGbCtD
Meloxicam—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.0282	0.0561	CbGbCtD
Meloxicam—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0244	0.0485	CbGbCtD
Meloxicam—PTGS1—Nateglinide—type 2 diabetes mellitus	0.0231	0.046	CbGbCtD
Meloxicam—PTGS1—Irbesartan—type 2 diabetes mellitus	0.0222	0.0441	CbGbCtD
Meloxicam—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0195	0.0388	CbGbCtD
Meloxicam—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0176	0.0351	CbGbCtD
Meloxicam—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.017	0.0338	CbGbCtD
Meloxicam—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0163	0.0324	CbGbCtD
Meloxicam—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0157	0.0313	CbGbCtD
Meloxicam—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0155	0.0309	CbGbCtD
Meloxicam—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0144	0.0288	CbGbCtD
Meloxicam—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0128	0.0255	CbGbCtD
Meloxicam—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0123	0.0245	CbGbCtD
Meloxicam—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0123	0.0245	CbGbCtD
Meloxicam—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0113	0.0226	CbGbCtD
Meloxicam—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0111	0.0221	CbGbCtD
Meloxicam—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0109	0.0218	CbGbCtD
Meloxicam—CYP2C9—Valsartan—type 2 diabetes mellitus	0.01	0.0199	CbGbCtD
Meloxicam—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00988	0.0197	CbGbCtD
Meloxicam—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00931	0.0185	CbGbCtD
Meloxicam—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00903	0.018	CbGbCtD
Meloxicam—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00892	0.0178	CbGbCtD
Meloxicam—CYP2C8—Losartan—type 2 diabetes mellitus	0.00825	0.0164	CbGbCtD
Meloxicam—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0079	0.0157	CbGbCtD
Meloxicam—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00714	0.0142	CbGbCtD
Meloxicam—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00629	0.0125	CbGbCtD
Meloxicam—CYP2C9—Losartan—type 2 diabetes mellitus	0.00575	0.0114	CbGbCtD
Meloxicam—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00541	0.0108	CbGbCtD
Meloxicam—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00519	0.0103	CbGbCtD
Meloxicam—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00519	0.0103	CbGbCtD
Meloxicam—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00491	0.00977	CbGbCtD
Meloxicam—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00366	0.00728	CbGbCtD
Meloxicam—CYP3A4—Losartan—type 2 diabetes mellitus	0.00334	0.00666	CbGbCtD
Meloxicam—PTGS2—leg—type 2 diabetes mellitus	0.00141	0.0809	CbGeAlD
Meloxicam—PTGS2—hindlimb—type 2 diabetes mellitus	0.00126	0.0722	CbGeAlD
Meloxicam—PGD—islet of Langerhans—type 2 diabetes mellitus	0.000929	0.0531	CbGeAlD
Meloxicam—PTGS1—artery—type 2 diabetes mellitus	0.00081	0.0463	CbGeAlD
Meloxicam—PGD—retina—type 2 diabetes mellitus	0.000794	0.0454	CbGeAlD
Meloxicam—PTGS2—artery—type 2 diabetes mellitus	0.000774	0.0443	CbGeAlD
Meloxicam—PGD—nephron tubule—type 2 diabetes mellitus	0.000748	0.0428	CbGeAlD
Meloxicam—PTGS1—endothelium—type 2 diabetes mellitus	0.000684	0.0391	CbGeAlD
Meloxicam—PGD—cardiovascular system—type 2 diabetes mellitus	0.000672	0.0384	CbGeAlD
Meloxicam—PGD—kidney—type 2 diabetes mellitus	0.000657	0.0376	CbGeAlD
Meloxicam—PTGS2—endothelium—type 2 diabetes mellitus	0.000654	0.0374	CbGeAlD
Meloxicam—PGD—cortex of kidney—type 2 diabetes mellitus	0.00064	0.0366	CbGeAlD
Meloxicam—PGD—adipose tissue—type 2 diabetes mellitus	0.000592	0.0339	CbGeAlD
Meloxicam—Lornoxicam—PTGS2—type 2 diabetes mellitus	0.00054	0.341	CrCbGaD
Meloxicam—ABCC4—nephron tubule—type 2 diabetes mellitus	0.000532	0.0304	CbGeAlD
Meloxicam—Tenoxicam—PTGS2—type 2 diabetes mellitus	0.000481	0.304	CrCbGaD
Meloxicam—ABCC4—kidney—type 2 diabetes mellitus	0.000468	0.0267	CbGeAlD
Meloxicam—ABCC4—pancreas—type 2 diabetes mellitus	0.000464	0.0266	CbGeAlD
Meloxicam—ABCC4—cortex of kidney—type 2 diabetes mellitus	0.000455	0.0261	CbGeAlD
Meloxicam—ABCC4—adipose tissue—type 2 diabetes mellitus	0.000421	0.0241	CbGeAlD
Meloxicam—PGD—liver—type 2 diabetes mellitus	0.000415	0.0238	CbGeAlD
Meloxicam—PTGS2—islet of Langerhans—type 2 diabetes mellitus	0.000372	0.0213	CbGeAlD
Meloxicam—CYP2C8—kidney—type 2 diabetes mellitus	0.000339	0.0194	CbGeAlD
Meloxicam—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000308	0.0176	CbGeAlD
Meloxicam—Piroxicam—PTGS2—type 2 diabetes mellitus	0.000297	0.188	CrCbGaD
Meloxicam—ABCC4—liver—type 2 diabetes mellitus	0.000296	0.0169	CbGeAlD
Meloxicam—PTGS1—cardiovascular system—type 2 diabetes mellitus	0.000281	0.0161	CbGeAlD
Meloxicam—PTGS1—kidney—type 2 diabetes mellitus	0.000275	0.0157	CbGeAlD
Meloxicam—PTGS2—cardiovascular system—type 2 diabetes mellitus	0.000269	0.0154	CbGeAlD
Meloxicam—Piroxicam—ALB—type 2 diabetes mellitus	0.000265	0.167	CrCbGaD
Meloxicam—PTGS2—kidney—type 2 diabetes mellitus	0.000263	0.0151	CbGeAlD
Meloxicam—PTGS2—pancreas—type 2 diabetes mellitus	0.000261	0.015	CbGeAlD
Meloxicam—PTGS1—adipose tissue—type 2 diabetes mellitus	0.000248	0.0142	CbGeAlD
Meloxicam—PTGS2—adipose tissue—type 2 diabetes mellitus	0.000237	0.0136	CbGeAlD
Meloxicam—CYP3A4—kidney—type 2 diabetes mellitus	0.00023	0.0132	CbGeAlD
Meloxicam—CYP2C8—liver—type 2 diabetes mellitus	0.000215	0.0123	CbGeAlD
Meloxicam—CYP2C9—liver—type 2 diabetes mellitus	0.000191	0.0109	CbGeAlD
Meloxicam—PTGS2—liver—type 2 diabetes mellitus	0.000166	0.00951	CbGeAlD
Meloxicam—CYP3A4—liver—type 2 diabetes mellitus	0.000145	0.00831	CbGeAlD
Meloxicam—Shock—Metformin—type 2 diabetes mellitus	6.23e-05	0.000367	CcSEcCtD
Meloxicam—Insomnia—Orlistat—type 2 diabetes mellitus	6.21e-05	0.000366	CcSEcCtD
Meloxicam—Malaise—Losartan—type 2 diabetes mellitus	6.21e-05	0.000366	CcSEcCtD
Meloxicam—Anxiety—Irbesartan—type 2 diabetes mellitus	6.21e-05	0.000366	CcSEcCtD
Meloxicam—Hypersensitivity—Glyburide—type 2 diabetes mellitus	6.21e-05	0.000365	CcSEcCtD
Meloxicam—Nervous system disorder—Metformin—type 2 diabetes mellitus	6.21e-05	0.000365	CcSEcCtD
Meloxicam—Thrombocytopenia—Metformin—type 2 diabetes mellitus	6.2e-05	0.000365	CcSEcCtD
Meloxicam—Dyspnoea—Valsartan—type 2 diabetes mellitus	6.19e-05	0.000365	CcSEcCtD
Meloxicam—Vertigo—Losartan—type 2 diabetes mellitus	6.19e-05	0.000364	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	6.19e-05	0.000364	CcSEcCtD
Meloxicam—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	6.18e-05	0.000364	CcSEcCtD
Meloxicam—Somnolence—Valsartan—type 2 diabetes mellitus	6.18e-05	0.000364	CcSEcCtD
Meloxicam—Syncope—Losartan—type 2 diabetes mellitus	6.17e-05	0.000364	CcSEcCtD
Meloxicam—Paraesthesia—Orlistat—type 2 diabetes mellitus	6.17e-05	0.000363	CcSEcCtD
Meloxicam—Leukopenia—Losartan—type 2 diabetes mellitus	6.16e-05	0.000363	CcSEcCtD
Meloxicam—Discomfort—Irbesartan—type 2 diabetes mellitus	6.15e-05	0.000362	CcSEcCtD
Meloxicam—Skin disorder—Metformin—type 2 diabetes mellitus	6.15e-05	0.000362	CcSEcCtD
Meloxicam—Immune system disorder—Ramipril—type 2 diabetes mellitus	6.13e-05	0.000361	CcSEcCtD
Meloxicam—Hyperhidrosis—Metformin—type 2 diabetes mellitus	6.12e-05	0.00036	CcSEcCtD
Meloxicam—Dyspepsia—Valsartan—type 2 diabetes mellitus	6.12e-05	0.00036	CcSEcCtD
Meloxicam—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	6.11e-05	0.00036	CcSEcCtD
Meloxicam—Dizziness—Bromocriptine—type 2 diabetes mellitus	6.09e-05	0.000359	CcSEcCtD
Meloxicam—Dry mouth—Irbesartan—type 2 diabetes mellitus	6.09e-05	0.000359	CcSEcCtD
Meloxicam—Palpitations—Losartan—type 2 diabetes mellitus	6.08e-05	0.000358	CcSEcCtD
Meloxicam—Nausea—Glimepiride—type 2 diabetes mellitus	6.07e-05	0.000357	CcSEcCtD
Meloxicam—Arrhythmia—Ramipril—type 2 diabetes mellitus	6.06e-05	0.000357	CcSEcCtD
Meloxicam—Loss of consciousness—Losartan—type 2 diabetes mellitus	6.05e-05	0.000356	CcSEcCtD
Meloxicam—Nausea—Sitagliptin—type 2 diabetes mellitus	6.05e-05	0.000356	CcSEcCtD
Meloxicam—Dyspepsia—Orlistat—type 2 diabetes mellitus	6.04e-05	0.000356	CcSEcCtD
Meloxicam—Asthenia—Glyburide—type 2 diabetes mellitus	6.04e-05	0.000356	CcSEcCtD
Meloxicam—Decreased appetite—Valsartan—type 2 diabetes mellitus	6.04e-05	0.000356	CcSEcCtD
Meloxicam—Cough—Losartan—type 2 diabetes mellitus	6.01e-05	0.000354	CcSEcCtD
Meloxicam—Urticaria—Gliclazide—type 2 diabetes mellitus	6.01e-05	0.000354	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	6e-05	0.000353	CcSEcCtD
Meloxicam—Alopecia—Ramipril—type 2 diabetes mellitus	5.99e-05	0.000353	CcSEcCtD
Meloxicam—Fatigue—Valsartan—type 2 diabetes mellitus	5.99e-05	0.000353	CcSEcCtD
Meloxicam—Body temperature increased—Gliclazide—type 2 diabetes mellitus	5.98e-05	0.000352	CcSEcCtD
Meloxicam—Abdominal pain—Gliclazide—type 2 diabetes mellitus	5.98e-05	0.000352	CcSEcCtD
Meloxicam—Oedema—Irbesartan—type 2 diabetes mellitus	5.97e-05	0.000352	CcSEcCtD
Meloxicam—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	5.97e-05	0.000352	CcSEcCtD
Meloxicam—Decreased appetite—Orlistat—type 2 diabetes mellitus	5.97e-05	0.000351	CcSEcCtD
Meloxicam—Pruritus—Glyburide—type 2 diabetes mellitus	5.96e-05	0.000351	CcSEcCtD
Meloxicam—Mental disorder—Ramipril—type 2 diabetes mellitus	5.94e-05	0.00035	CcSEcCtD
Meloxicam—Constipation—Valsartan—type 2 diabetes mellitus	5.94e-05	0.00035	CcSEcCtD
Meloxicam—Infection—Irbesartan—type 2 diabetes mellitus	5.93e-05	0.000349	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	5.93e-05	0.000349	CcSEcCtD
Meloxicam—Fatigue—Orlistat—type 2 diabetes mellitus	5.92e-05	0.000349	CcSEcCtD
Meloxicam—Hypotension—Metformin—type 2 diabetes mellitus	5.91e-05	0.000348	CcSEcCtD
Meloxicam—Erythema—Ramipril—type 2 diabetes mellitus	5.9e-05	0.000348	CcSEcCtD
Meloxicam—Malnutrition—Ramipril—type 2 diabetes mellitus	5.9e-05	0.000348	CcSEcCtD
Meloxicam—Shock—Irbesartan—type 2 diabetes mellitus	5.87e-05	0.000346	CcSEcCtD
Meloxicam—Pain—Orlistat—type 2 diabetes mellitus	5.87e-05	0.000346	CcSEcCtD
Meloxicam—Myalgia—Losartan—type 2 diabetes mellitus	5.86e-05	0.000345	CcSEcCtD
Meloxicam—Arthralgia—Losartan—type 2 diabetes mellitus	5.86e-05	0.000345	CcSEcCtD
Meloxicam—Vomiting—Bromocriptine—type 2 diabetes mellitus	5.86e-05	0.000345	CcSEcCtD
Meloxicam—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	5.86e-05	0.000345	CcSEcCtD
Meloxicam—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	5.85e-05	0.000344	CcSEcCtD
Meloxicam—Anxiety—Losartan—type 2 diabetes mellitus	5.84e-05	0.000344	CcSEcCtD
Meloxicam—Tachycardia—Irbesartan—type 2 diabetes mellitus	5.83e-05	0.000343	CcSEcCtD
Meloxicam—Rash—Bromocriptine—type 2 diabetes mellitus	5.81e-05	0.000342	CcSEcCtD
Meloxicam—Dermatitis—Bromocriptine—type 2 diabetes mellitus	5.8e-05	0.000342	CcSEcCtD
Meloxicam—Skin disorder—Irbesartan—type 2 diabetes mellitus	5.8e-05	0.000342	CcSEcCtD
Meloxicam—Tension—Ramipril—type 2 diabetes mellitus	5.79e-05	0.000341	CcSEcCtD
Meloxicam—Discomfort—Losartan—type 2 diabetes mellitus	5.79e-05	0.000341	CcSEcCtD
Meloxicam—Dysgeusia—Ramipril—type 2 diabetes mellitus	5.78e-05	0.00034	CcSEcCtD
Meloxicam—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	5.77e-05	0.00034	CcSEcCtD
Meloxicam—Headache—Bromocriptine—type 2 diabetes mellitus	5.77e-05	0.00034	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	5.76e-05	0.000339	CcSEcCtD
Meloxicam—Diarrhoea—Glyburide—type 2 diabetes mellitus	5.76e-05	0.000339	CcSEcCtD
Meloxicam—Nervousness—Ramipril—type 2 diabetes mellitus	5.73e-05	0.000338	CcSEcCtD
Meloxicam—Dry mouth—Losartan—type 2 diabetes mellitus	5.73e-05	0.000338	CcSEcCtD
Meloxicam—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	5.68e-05	0.000335	CcSEcCtD
Meloxicam—Paraesthesia—Metformin—type 2 diabetes mellitus	5.68e-05	0.000335	CcSEcCtD
Meloxicam—Muscle spasms—Ramipril—type 2 diabetes mellitus	5.68e-05	0.000334	CcSEcCtD
Meloxicam—Confusional state—Losartan—type 2 diabetes mellitus	5.67e-05	0.000334	CcSEcCtD
Meloxicam—Feeling abnormal—Orlistat—type 2 diabetes mellitus	5.66e-05	0.000333	CcSEcCtD
Meloxicam—Dyspnoea—Metformin—type 2 diabetes mellitus	5.64e-05	0.000332	CcSEcCtD
Meloxicam—Somnolence—Metformin—type 2 diabetes mellitus	5.63e-05	0.000331	CcSEcCtD
Meloxicam—Oedema—Losartan—type 2 diabetes mellitus	5.62e-05	0.000331	CcSEcCtD
Meloxicam—Anaphylactic shock—Losartan—type 2 diabetes mellitus	5.62e-05	0.000331	CcSEcCtD
Meloxicam—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	5.61e-05	0.000331	CcSEcCtD
Meloxicam—Infection—Losartan—type 2 diabetes mellitus	5.58e-05	0.000329	CcSEcCtD
Meloxicam—Hypotension—Irbesartan—type 2 diabetes mellitus	5.58e-05	0.000329	CcSEcCtD
Meloxicam—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	5.57e-05	0.000328	CcSEcCtD
Meloxicam—Dyspepsia—Metformin—type 2 diabetes mellitus	5.57e-05	0.000328	CcSEcCtD
Meloxicam—Tremor—Ramipril—type 2 diabetes mellitus	5.53e-05	0.000326	CcSEcCtD
Meloxicam—Shock—Losartan—type 2 diabetes mellitus	5.53e-05	0.000326	CcSEcCtD
Meloxicam—Urticaria—Valsartan—type 2 diabetes mellitus	5.52e-05	0.000325	CcSEcCtD
Meloxicam—Nervous system disorder—Losartan—type 2 diabetes mellitus	5.51e-05	0.000324	CcSEcCtD
Meloxicam—Thrombocytopenia—Losartan—type 2 diabetes mellitus	5.5e-05	0.000324	CcSEcCtD
Meloxicam—Decreased appetite—Metformin—type 2 diabetes mellitus	5.5e-05	0.000324	CcSEcCtD
Meloxicam—Abdominal pain—Valsartan—type 2 diabetes mellitus	5.49e-05	0.000323	CcSEcCtD
Meloxicam—Tachycardia—Losartan—type 2 diabetes mellitus	5.48e-05	0.000323	CcSEcCtD
Meloxicam—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	5.48e-05	0.000323	CcSEcCtD
Meloxicam—Nausea—Bromocriptine—type 2 diabetes mellitus	5.47e-05	0.000322	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	5.46e-05	0.000322	CcSEcCtD
Meloxicam—Fatigue—Metformin—type 2 diabetes mellitus	5.46e-05	0.000321	CcSEcCtD
Meloxicam—Urticaria—Orlistat—type 2 diabetes mellitus	5.45e-05	0.000321	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	5.44e-05	0.00032	CcSEcCtD
Meloxicam—Hyperhidrosis—Losartan—type 2 diabetes mellitus	5.43e-05	0.00032	CcSEcCtD
Meloxicam—Body temperature increased—Orlistat—type 2 diabetes mellitus	5.43e-05	0.00032	CcSEcCtD
Meloxicam—Abdominal pain—Orlistat—type 2 diabetes mellitus	5.43e-05	0.00032	CcSEcCtD
Meloxicam—Asthenia—Gliclazide—type 2 diabetes mellitus	5.43e-05	0.000319	CcSEcCtD
Meloxicam—Constipation—Metformin—type 2 diabetes mellitus	5.41e-05	0.000319	CcSEcCtD
Meloxicam—Angioedema—Ramipril—type 2 diabetes mellitus	5.39e-05	0.000318	CcSEcCtD
Meloxicam—Paraesthesia—Irbesartan—type 2 diabetes mellitus	5.36e-05	0.000316	CcSEcCtD
Meloxicam—Vomiting—Glyburide—type 2 diabetes mellitus	5.35e-05	0.000315	CcSEcCtD
Meloxicam—Pruritus—Gliclazide—type 2 diabetes mellitus	5.35e-05	0.000315	CcSEcCtD
Meloxicam—Malaise—Ramipril—type 2 diabetes mellitus	5.32e-05	0.000313	CcSEcCtD
Meloxicam—Dyspnoea—Irbesartan—type 2 diabetes mellitus	5.32e-05	0.000313	CcSEcCtD
Meloxicam—Rash—Glyburide—type 2 diabetes mellitus	5.31e-05	0.000313	CcSEcCtD
Meloxicam—Somnolence—Irbesartan—type 2 diabetes mellitus	5.31e-05	0.000313	CcSEcCtD
Meloxicam—Dermatitis—Glyburide—type 2 diabetes mellitus	5.31e-05	0.000312	CcSEcCtD
Meloxicam—Vertigo—Ramipril—type 2 diabetes mellitus	5.3e-05	0.000312	CcSEcCtD
Meloxicam—Syncope—Ramipril—type 2 diabetes mellitus	5.29e-05	0.000312	CcSEcCtD
Meloxicam—Leukopenia—Ramipril—type 2 diabetes mellitus	5.28e-05	0.000311	CcSEcCtD
Meloxicam—Headache—Glyburide—type 2 diabetes mellitus	5.28e-05	0.000311	CcSEcCtD
Meloxicam—Dyspepsia—Irbesartan—type 2 diabetes mellitus	5.26e-05	0.000309	CcSEcCtD
Meloxicam—Hypotension—Losartan—type 2 diabetes mellitus	5.25e-05	0.000309	CcSEcCtD
Meloxicam—Palpitations—Ramipril—type 2 diabetes mellitus	5.22e-05	0.000307	CcSEcCtD
Meloxicam—Feeling abnormal—Metformin—type 2 diabetes mellitus	5.21e-05	0.000307	CcSEcCtD
Meloxicam—Decreased appetite—Irbesartan—type 2 diabetes mellitus	5.19e-05	0.000306	CcSEcCtD
Meloxicam—Loss of consciousness—Ramipril—type 2 diabetes mellitus	5.19e-05	0.000306	CcSEcCtD
Meloxicam—Diarrhoea—Gliclazide—type 2 diabetes mellitus	5.17e-05	0.000305	CcSEcCtD
Meloxicam—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	5.17e-05	0.000305	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	5.16e-05	0.000304	CcSEcCtD
Meloxicam—Cough—Ramipril—type 2 diabetes mellitus	5.15e-05	0.000303	CcSEcCtD
Meloxicam—Fatigue—Irbesartan—type 2 diabetes mellitus	5.15e-05	0.000303	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	5.12e-05	0.000301	CcSEcCtD
Meloxicam—Hypersensitivity—Valsartan—type 2 diabetes mellitus	5.12e-05	0.000301	CcSEcCtD
Meloxicam—Convulsion—Ramipril—type 2 diabetes mellitus	5.12e-05	0.000301	CcSEcCtD
Meloxicam—Constipation—Irbesartan—type 2 diabetes mellitus	5.11e-05	0.000301	CcSEcCtD
Meloxicam—Pain—Irbesartan—type 2 diabetes mellitus	5.11e-05	0.000301	CcSEcCtD
Meloxicam—Insomnia—Losartan—type 2 diabetes mellitus	5.08e-05	0.000299	CcSEcCtD
Meloxicam—Hypersensitivity—Orlistat—type 2 diabetes mellitus	5.06e-05	0.000298	CcSEcCtD
Meloxicam—Paraesthesia—Losartan—type 2 diabetes mellitus	5.05e-05	0.000297	CcSEcCtD
Meloxicam—Urticaria—Metformin—type 2 diabetes mellitus	5.03e-05	0.000296	CcSEcCtD
Meloxicam—Arthralgia—Ramipril—type 2 diabetes mellitus	5.03e-05	0.000296	CcSEcCtD
Meloxicam—Myalgia—Ramipril—type 2 diabetes mellitus	5.03e-05	0.000296	CcSEcCtD
Meloxicam—Dyspnoea—Losartan—type 2 diabetes mellitus	5.01e-05	0.000295	CcSEcCtD
Meloxicam—Anxiety—Ramipril—type 2 diabetes mellitus	5.01e-05	0.000295	CcSEcCtD
Meloxicam—Nausea—Glyburide—type 2 diabetes mellitus	5e-05	0.000295	CcSEcCtD
Meloxicam—Abdominal pain—Metformin—type 2 diabetes mellitus	5e-05	0.000295	CcSEcCtD
Meloxicam—Dizziness—Gliclazide—type 2 diabetes mellitus	5e-05	0.000294	CcSEcCtD
Meloxicam—Somnolence—Losartan—type 2 diabetes mellitus	5e-05	0.000294	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	4.99e-05	0.000294	CcSEcCtD
Meloxicam—Asthenia—Valsartan—type 2 diabetes mellitus	4.99e-05	0.000294	CcSEcCtD
Meloxicam—Discomfort—Ramipril—type 2 diabetes mellitus	4.97e-05	0.000292	CcSEcCtD
Meloxicam—Dyspepsia—Losartan—type 2 diabetes mellitus	4.95e-05	0.000291	CcSEcCtD
Meloxicam—Asthenia—Orlistat—type 2 diabetes mellitus	4.93e-05	0.00029	CcSEcCtD
Meloxicam—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	4.92e-05	0.00029	CcSEcCtD
Meloxicam—Pruritus—Valsartan—type 2 diabetes mellitus	4.92e-05	0.000289	CcSEcCtD
Meloxicam—Dry mouth—Ramipril—type 2 diabetes mellitus	4.92e-05	0.000289	CcSEcCtD
Meloxicam—Decreased appetite—Losartan—type 2 diabetes mellitus	4.88e-05	0.000288	CcSEcCtD
Meloxicam—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	4.88e-05	0.000288	CcSEcCtD
Meloxicam—Confusional state—Ramipril—type 2 diabetes mellitus	4.86e-05	0.000286	CcSEcCtD
Meloxicam—Pruritus—Orlistat—type 2 diabetes mellitus	4.86e-05	0.000286	CcSEcCtD
Meloxicam—Fatigue—Losartan—type 2 diabetes mellitus	4.84e-05	0.000285	CcSEcCtD
Meloxicam—Oedema—Ramipril—type 2 diabetes mellitus	4.82e-05	0.000284	CcSEcCtD
Meloxicam—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	4.82e-05	0.000284	CcSEcCtD
Meloxicam—Vomiting—Gliclazide—type 2 diabetes mellitus	4.81e-05	0.000283	CcSEcCtD
Meloxicam—Constipation—Losartan—type 2 diabetes mellitus	4.81e-05	0.000283	CcSEcCtD
Meloxicam—Pain—Losartan—type 2 diabetes mellitus	4.81e-05	0.000283	CcSEcCtD
Meloxicam—Rash—Gliclazide—type 2 diabetes mellitus	4.77e-05	0.000281	CcSEcCtD
Meloxicam—Dermatitis—Gliclazide—type 2 diabetes mellitus	4.76e-05	0.000281	CcSEcCtD
Meloxicam—Diarrhoea—Valsartan—type 2 diabetes mellitus	4.75e-05	0.00028	CcSEcCtD
Meloxicam—Urticaria—Irbesartan—type 2 diabetes mellitus	4.74e-05	0.000279	CcSEcCtD
Meloxicam—Shock—Ramipril—type 2 diabetes mellitus	4.74e-05	0.000279	CcSEcCtD
Meloxicam—Headache—Gliclazide—type 2 diabetes mellitus	4.74e-05	0.000279	CcSEcCtD
Meloxicam—Nervous system disorder—Ramipril—type 2 diabetes mellitus	4.73e-05	0.000278	CcSEcCtD
Meloxicam—Abdominal pain—Irbesartan—type 2 diabetes mellitus	4.72e-05	0.000278	CcSEcCtD
Meloxicam—Body temperature increased—Irbesartan—type 2 diabetes mellitus	4.72e-05	0.000278	CcSEcCtD
Meloxicam—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	4.72e-05	0.000278	CcSEcCtD
Meloxicam—Tachycardia—Ramipril—type 2 diabetes mellitus	4.7e-05	0.000277	CcSEcCtD
Meloxicam—Diarrhoea—Orlistat—type 2 diabetes mellitus	4.7e-05	0.000277	CcSEcCtD
Meloxicam—Skin disorder—Ramipril—type 2 diabetes mellitus	4.68e-05	0.000276	CcSEcCtD
Meloxicam—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	4.66e-05	0.000274	CcSEcCtD
Meloxicam—Feeling abnormal—Losartan—type 2 diabetes mellitus	4.63e-05	0.000273	CcSEcCtD
Meloxicam—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	4.6e-05	0.000271	CcSEcCtD
Meloxicam—Dizziness—Valsartan—type 2 diabetes mellitus	4.59e-05	0.000271	CcSEcCtD
Meloxicam—Dizziness—Orlistat—type 2 diabetes mellitus	4.54e-05	0.000267	CcSEcCtD
Meloxicam—Asthenia—Metformin—type 2 diabetes mellitus	4.54e-05	0.000267	CcSEcCtD
Meloxicam—Hypotension—Ramipril—type 2 diabetes mellitus	4.5e-05	0.000265	CcSEcCtD
Meloxicam—Nausea—Gliclazide—type 2 diabetes mellitus	4.49e-05	0.000265	CcSEcCtD
Meloxicam—Pruritus—Metformin—type 2 diabetes mellitus	4.48e-05	0.000264	CcSEcCtD
Meloxicam—Urticaria—Losartan—type 2 diabetes mellitus	4.46e-05	0.000263	CcSEcCtD
Meloxicam—Abdominal pain—Losartan—type 2 diabetes mellitus	4.44e-05	0.000262	CcSEcCtD
Meloxicam—Body temperature increased—Losartan—type 2 diabetes mellitus	4.44e-05	0.000262	CcSEcCtD
Meloxicam—Vomiting—Valsartan—type 2 diabetes mellitus	4.42e-05	0.00026	CcSEcCtD
Meloxicam—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	4.4e-05	0.000259	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	4.39e-05	0.000258	CcSEcCtD
Meloxicam—Rash—Valsartan—type 2 diabetes mellitus	4.38e-05	0.000258	CcSEcCtD
Meloxicam—Dermatitis—Valsartan—type 2 diabetes mellitus	4.38e-05	0.000258	CcSEcCtD
Meloxicam—Vomiting—Orlistat—type 2 diabetes mellitus	4.37e-05	0.000257	CcSEcCtD
Meloxicam—Insomnia—Ramipril—type 2 diabetes mellitus	4.36e-05	0.000257	CcSEcCtD
Meloxicam—Headache—Valsartan—type 2 diabetes mellitus	4.35e-05	0.000256	CcSEcCtD
Meloxicam—Diarrhoea—Metformin—type 2 diabetes mellitus	4.33e-05	0.000255	CcSEcCtD
Meloxicam—Rash—Orlistat—type 2 diabetes mellitus	4.33e-05	0.000255	CcSEcCtD
Meloxicam—Paraesthesia—Ramipril—type 2 diabetes mellitus	4.33e-05	0.000255	CcSEcCtD
Meloxicam—Dermatitis—Orlistat—type 2 diabetes mellitus	4.32e-05	0.000255	CcSEcCtD
Meloxicam—Headache—Orlistat—type 2 diabetes mellitus	4.3e-05	0.000253	CcSEcCtD
Meloxicam—Dyspnoea—Ramipril—type 2 diabetes mellitus	4.3e-05	0.000253	CcSEcCtD
Meloxicam—Asthenia—Irbesartan—type 2 diabetes mellitus	4.28e-05	0.000252	CcSEcCtD
Meloxicam—Somnolence—Ramipril—type 2 diabetes mellitus	4.28e-05	0.000252	CcSEcCtD
Meloxicam—Dyspepsia—Ramipril—type 2 diabetes mellitus	4.24e-05	0.00025	CcSEcCtD
Meloxicam—Pruritus—Irbesartan—type 2 diabetes mellitus	4.22e-05	0.000249	CcSEcCtD
Meloxicam—Decreased appetite—Ramipril—type 2 diabetes mellitus	4.19e-05	0.000247	CcSEcCtD
Meloxicam—Dizziness—Metformin—type 2 diabetes mellitus	4.18e-05	0.000246	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	4.16e-05	0.000245	CcSEcCtD
Meloxicam—Fatigue—Ramipril—type 2 diabetes mellitus	4.15e-05	0.000245	CcSEcCtD
Meloxicam—Hypersensitivity—Losartan—type 2 diabetes mellitus	4.14e-05	0.000244	CcSEcCtD
Meloxicam—Nausea—Valsartan—type 2 diabetes mellitus	4.13e-05	0.000243	CcSEcCtD
Meloxicam—Constipation—Ramipril—type 2 diabetes mellitus	4.12e-05	0.000243	CcSEcCtD
Meloxicam—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.09e-05	0.000241	CcSEcCtD
Meloxicam—Nausea—Orlistat—type 2 diabetes mellitus	4.08e-05	0.00024	CcSEcCtD
Meloxicam—Asthenia—Losartan—type 2 diabetes mellitus	4.03e-05	0.000237	CcSEcCtD
Meloxicam—Vomiting—Metformin—type 2 diabetes mellitus	4.02e-05	0.000237	CcSEcCtD
Meloxicam—Rash—Metformin—type 2 diabetes mellitus	3.99e-05	0.000235	CcSEcCtD
Meloxicam—Dermatitis—Metformin—type 2 diabetes mellitus	3.99e-05	0.000235	CcSEcCtD
Meloxicam—Pruritus—Losartan—type 2 diabetes mellitus	3.98e-05	0.000234	CcSEcCtD
Meloxicam—Feeling abnormal—Ramipril—type 2 diabetes mellitus	3.97e-05	0.000234	CcSEcCtD
Meloxicam—Headache—Metformin—type 2 diabetes mellitus	3.96e-05	0.000233	CcSEcCtD
Meloxicam—Dizziness—Irbesartan—type 2 diabetes mellitus	3.95e-05	0.000233	CcSEcCtD
Meloxicam—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.94e-05	0.000232	CcSEcCtD
Meloxicam—Diarrhoea—Losartan—type 2 diabetes mellitus	3.84e-05	0.000226	CcSEcCtD
Meloxicam—Urticaria—Ramipril—type 2 diabetes mellitus	3.83e-05	0.000225	CcSEcCtD
Meloxicam—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.81e-05	0.000224	CcSEcCtD
Meloxicam—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.81e-05	0.000224	CcSEcCtD
Meloxicam—Vomiting—Irbesartan—type 2 diabetes mellitus	3.8e-05	0.000224	CcSEcCtD
Meloxicam—Rash—Irbesartan—type 2 diabetes mellitus	3.76e-05	0.000222	CcSEcCtD
Meloxicam—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.76e-05	0.000221	CcSEcCtD
Meloxicam—Nausea—Metformin—type 2 diabetes mellitus	3.76e-05	0.000221	CcSEcCtD
Meloxicam—Headache—Irbesartan—type 2 diabetes mellitus	3.74e-05	0.00022	CcSEcCtD
Meloxicam—Dizziness—Losartan—type 2 diabetes mellitus	3.72e-05	0.000219	CcSEcCtD
Meloxicam—Vomiting—Losartan—type 2 diabetes mellitus	3.57e-05	0.00021	CcSEcCtD
Meloxicam—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.55e-05	0.000209	CcSEcCtD
Meloxicam—Nausea—Irbesartan—type 2 diabetes mellitus	3.55e-05	0.000209	CcSEcCtD
Meloxicam—Rash—Losartan—type 2 diabetes mellitus	3.54e-05	0.000209	CcSEcCtD
Meloxicam—Dermatitis—Losartan—type 2 diabetes mellitus	3.54e-05	0.000208	CcSEcCtD
Meloxicam—Headache—Losartan—type 2 diabetes mellitus	3.52e-05	0.000207	CcSEcCtD
Meloxicam—Asthenia—Ramipril—type 2 diabetes mellitus	3.46e-05	0.000204	CcSEcCtD
Meloxicam—Pruritus—Ramipril—type 2 diabetes mellitus	3.41e-05	0.000201	CcSEcCtD
Meloxicam—Nausea—Losartan—type 2 diabetes mellitus	3.34e-05	0.000197	CcSEcCtD
Meloxicam—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.3e-05	0.000194	CcSEcCtD
Meloxicam—Dizziness—Ramipril—type 2 diabetes mellitus	3.19e-05	0.000188	CcSEcCtD
Meloxicam—Vomiting—Ramipril—type 2 diabetes mellitus	3.06e-05	0.00018	CcSEcCtD
Meloxicam—Rash—Ramipril—type 2 diabetes mellitus	3.04e-05	0.000179	CcSEcCtD
Meloxicam—Dermatitis—Ramipril—type 2 diabetes mellitus	3.04e-05	0.000179	CcSEcCtD
Meloxicam—Headache—Ramipril—type 2 diabetes mellitus	3.02e-05	0.000178	CcSEcCtD
Meloxicam—Nausea—Ramipril—type 2 diabetes mellitus	2.86e-05	0.000169	CcSEcCtD
Meloxicam—CYP2C9—Metabolism—LPA—type 2 diabetes mellitus	7.3e-06	0.000117	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—HSD3B2—type 2 diabetes mellitus	7.3e-06	0.000117	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CAT—type 2 diabetes mellitus	7.26e-06	0.000116	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	7.24e-06	0.000116	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYP2E1—type 2 diabetes mellitus	7.19e-06	0.000115	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—NAMPT—type 2 diabetes mellitus	7.17e-06	0.000115	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	7.13e-06	0.000114	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—HBA1—type 2 diabetes mellitus	7.13e-06	0.000114	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—LIPC—type 2 diabetes mellitus	7.13e-06	0.000114	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GCK—type 2 diabetes mellitus	7.13e-06	0.000114	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—SLC2A1—type 2 diabetes mellitus	7.11e-06	0.000114	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYP1A2—type 2 diabetes mellitus	7.11e-06	0.000114	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP11A1—type 2 diabetes mellitus	7.08e-06	0.000113	CbGpPWpGaD
Meloxicam—PTGS2—Disease—TGFBR2—type 2 diabetes mellitus	7.08e-06	0.000113	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—APOB—type 2 diabetes mellitus	7.05e-06	0.000113	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	7.02e-06	0.000112	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALDOB—type 2 diabetes mellitus	7e-06	0.000112	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—SLC9A1—type 2 diabetes mellitus	6.96e-06	0.000111	CbGpPWpGaD
Meloxicam—PGD—Metabolism—AKT1—type 2 diabetes mellitus	6.93e-06	0.000111	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CYP3A4—type 2 diabetes mellitus	6.93e-06	0.000111	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CETP—type 2 diabetes mellitus	6.88e-06	0.00011	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GSTM1—type 2 diabetes mellitus	6.86e-06	0.00011	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CDKN2B—type 2 diabetes mellitus	6.86e-06	0.00011	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	6.83e-06	0.000109	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	6.83e-06	0.000109	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GCG—type 2 diabetes mellitus	6.81e-06	0.000109	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—SLC2A4—type 2 diabetes mellitus	6.81e-06	0.000109	CbGpPWpGaD
Meloxicam—ABCC4—Hemostasis—AKT1—type 2 diabetes mellitus	6.8e-06	0.000109	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	6.8e-06	0.000109	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—LPL—type 2 diabetes mellitus	6.73e-06	0.000108	CbGpPWpGaD
Meloxicam—PTGS2—Disease—APOB—type 2 diabetes mellitus	6.68e-06	0.000107	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	6.66e-06	0.000107	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	6.66e-06	0.000107	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ADCY5—type 2 diabetes mellitus	6.59e-06	0.000106	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	6.59e-06	0.000105	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—GPX1—type 2 diabetes mellitus	6.57e-06	0.000105	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GLP1R—type 2 diabetes mellitus	6.51e-06	0.000104	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.41e-06	0.000103	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CD36—type 2 diabetes mellitus	6.4e-06	0.000102	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—SREBF1—type 2 diabetes mellitus	6.39e-06	0.000102	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PSMD6—type 2 diabetes mellitus	6.39e-06	0.000102	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—SNAP25—type 2 diabetes mellitus	6.39e-06	0.000102	CbGpPWpGaD
Meloxicam—PTGS2—Disease—LPL—type 2 diabetes mellitus	6.38e-06	0.000102	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	6.35e-06	0.000102	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	6.35e-06	0.000102	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	6.35e-06	0.000102	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PPP2CA—type 2 diabetes mellitus	6.32e-06	0.000101	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CTGF—type 2 diabetes mellitus	6.27e-06	0.0001	CbGpPWpGaD
Meloxicam—PTGS2—Disease—ADCY5—type 2 diabetes mellitus	6.25e-06	0.0001	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—HMGCR—type 2 diabetes mellitus	6.22e-06	9.96e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.13e-06	9.82e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	6.09e-06	9.76e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	6.09e-06	9.76e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ADRA2A—type 2 diabetes mellitus	6.09e-06	9.75e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—SLC2A2—type 2 diabetes mellitus	6.08e-06	9.73e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—MTHFR—type 2 diabetes mellitus	6.06e-06	9.71e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PPP2CA—type 2 diabetes mellitus	5.99e-06	9.59e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—MTR—type 2 diabetes mellitus	5.95e-06	9.53e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CPT1A—type 2 diabetes mellitus	5.95e-06	9.53e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PPARA—type 2 diabetes mellitus	5.95e-06	9.53e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CCR5—type 2 diabetes mellitus	5.88e-06	9.42e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.87e-06	9.4e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GNB3—type 2 diabetes mellitus	5.87e-06	9.4e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	5.86e-06	9.39e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	5.86e-06	9.39e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP2E1—type 2 diabetes mellitus	5.85e-06	9.36e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—HMOX1—type 2 diabetes mellitus	5.84e-06	9.36e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—NAMPT—type 2 diabetes mellitus	5.84e-06	9.35e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	5.8e-06	9.29e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—LIPC—type 2 diabetes mellitus	5.8e-06	9.29e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—HBA1—type 2 diabetes mellitus	5.8e-06	9.29e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GCK—type 2 diabetes mellitus	5.8e-06	9.29e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	5.78e-06	9.26e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	5.78e-06	9.26e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CAT—type 2 diabetes mellitus	5.77e-06	9.23e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP11A1—type 2 diabetes mellitus	5.76e-06	9.23e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	5.76e-06	9.23e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—AGT—type 2 diabetes mellitus	5.76e-06	9.23e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—MTHFR—type 2 diabetes mellitus	5.75e-06	9.2e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—CALM1—type 2 diabetes mellitus	5.66e-06	9.07e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	5.66e-06	9.07e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	5.66e-06	9.07e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	5.66e-06	9.07e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—SLC9A1—type 2 diabetes mellitus	5.66e-06	9.07e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—APOE—type 2 diabetes mellitus	5.64e-06	9.04e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	5.64e-06	9.03e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.61e-06	8.98e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—APOB—type 2 diabetes mellitus	5.6e-06	8.97e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	5.6e-06	8.96e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—APOA1—type 2 diabetes mellitus	5.58e-06	8.94e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	5.54e-06	8.88e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	5.54e-06	8.88e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—HIF1A—type 2 diabetes mellitus	5.48e-06	8.78e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IRS2—type 2 diabetes mellitus	5.47e-06	8.76e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GSTM1—type 2 diabetes mellitus	5.45e-06	8.72e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—CALM1—type 2 diabetes mellitus	5.37e-06	8.6e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—APOE—type 2 diabetes mellitus	5.35e-06	8.57e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—LPL—type 2 diabetes mellitus	5.35e-06	8.56e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	5.32e-06	8.53e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—APOA1—type 2 diabetes mellitus	5.29e-06	8.47e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ADCY5—type 2 diabetes mellitus	5.23e-06	8.38e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	5.22e-06	8.36e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—GPX1—type 2 diabetes mellitus	5.22e-06	8.35e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	5.2e-06	8.33e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	5.2e-06	8.33e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	5.2e-06	8.33e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	5.11e-06	8.18e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CD36—type 2 diabetes mellitus	5.08e-06	8.13e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	5.06e-06	8.11e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PPP2CA—type 2 diabetes mellitus	5.02e-06	8.03e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.99e-06	7.99e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.99e-06	7.99e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NOS2—type 2 diabetes mellitus	4.99e-06	7.98e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	4.95e-06	7.93e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	4.92e-06	7.87e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—INS—type 2 diabetes mellitus	4.82e-06	7.72e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.82e-06	7.71e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.82e-06	7.71e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.82e-06	7.71e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.82e-06	7.71e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—MTHFR—type 2 diabetes mellitus	4.81e-06	7.71e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	4.78e-06	7.65e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.78e-06	7.65e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IRS1—type 2 diabetes mellitus	4.77e-06	7.64e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	4.76e-06	7.62e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	4.76e-06	7.62e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PPARA—type 2 diabetes mellitus	4.72e-06	7.56e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	4.71e-06	7.54e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	4.71e-06	7.54e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	4.69e-06	7.51e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.62e-06	7.39e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	4.59e-06	7.35e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—AGT—type 2 diabetes mellitus	4.57e-06	7.32e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—INS—type 2 diabetes mellitus	4.57e-06	7.32e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.57e-06	7.31e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	4.56e-06	7.29e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	4.51e-06	7.22e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	4.51e-06	7.22e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—CALM1—type 2 diabetes mellitus	4.5e-06	7.2e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—APOE—type 2 diabetes mellitus	4.48e-06	7.18e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	4.43e-06	7.1e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—APOA1—type 2 diabetes mellitus	4.43e-06	7.09e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	4.42e-06	7.08e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—AKT2—type 2 diabetes mellitus	4.42e-06	7.07e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	4.35e-06	6.97e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.29e-06	6.87e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	4.26e-06	6.82e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	4.24e-06	6.8e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	4.23e-06	6.77e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.23e-06	6.77e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SERPINE1—type 2 diabetes mellitus	4.2e-06	6.72e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	4.13e-06	6.62e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	4.08e-06	6.54e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—NOS3—type 2 diabetes mellitus	4.01e-06	6.42e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—PIK3R1—type 2 diabetes mellitus	4.01e-06	6.42e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.01e-06	6.42e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.93e-06	6.29e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.93e-06	6.29e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	3.92e-06	6.27e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PPARG—type 2 diabetes mellitus	3.9e-06	6.25e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	3.89e-06	6.23e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.89e-06	6.23e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	3.87e-06	6.2e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	3.87e-06	6.19e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.85e-06	6.17e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	3.84e-06	6.15e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—INS—type 2 diabetes mellitus	3.83e-06	6.13e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.83e-06	6.13e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.83e-06	6.13e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.83e-06	6.13e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	3.82e-06	6.12e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.8e-06	6.09e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.73e-06	5.98e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	3.72e-06	5.96e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	3.71e-06	5.94e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.69e-06	5.91e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	3.66e-06	5.86e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	3.65e-06	5.84e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	3.61e-06	5.78e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	3.6e-06	5.77e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	3.54e-06	5.67e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—ALB—type 2 diabetes mellitus	3.51e-06	5.62e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	3.47e-06	5.55e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	3.45e-06	5.53e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.43e-06	5.5e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.43e-06	5.5e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.43e-06	5.5e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.37e-06	5.39e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	3.36e-06	5.39e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—PIK3R1—type 2 diabetes mellitus	3.36e-06	5.38e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—NOS3—type 2 diabetes mellitus	3.36e-06	5.38e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.34e-06	5.35e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	3.32e-06	5.32e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.27e-06	5.23e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	3.19e-06	5.1e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	3.18e-06	5.09e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.14e-06	5.03e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	3.13e-06	5.01e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	3.11e-06	4.99e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.1e-06	4.97e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.1e-06	4.97e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	3.03e-06	4.85e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.98e-06	4.77e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.98e-06	4.76e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.98e-06	4.76e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.97e-06	4.75e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—SRC—type 2 diabetes mellitus	2.96e-06	4.75e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.93e-06	4.7e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	2.86e-06	4.57e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	2.73e-06	4.37e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	2.73e-06	4.37e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—TGFB1—type 2 diabetes mellitus	2.65e-06	4.24e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—EGFR—type 2 diabetes mellitus	2.6e-06	4.16e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.58e-06	4.14e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.56e-06	4.11e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.56e-06	4.11e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.55e-06	4.09e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.53e-06	4.06e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.52e-06	4.03e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	2.5e-06	4e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.44e-06	3.92e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.38e-06	3.81e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.33e-06	3.74e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.32e-06	3.72e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.29e-06	3.66e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.28e-06	3.65e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	2.22e-06	3.56e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.22e-06	3.56e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.22e-06	3.55e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.19e-06	3.51e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.1e-06	3.37e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.06e-06	3.3e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	2.03e-06	3.26e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2e-06	3.2e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—IL6—type 2 diabetes mellitus	2e-06	3.2e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.96e-06	3.14e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.96e-06	3.13e-05	CbGpPWpGaD
Meloxicam—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	1.94e-06	3.11e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.93e-06	3.1e-05	CbGpPWpGaD
Meloxicam—PTGS2—Disease—AKT1—type 2 diabetes mellitus	1.84e-06	2.95e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.7e-06	2.73e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.67e-06	2.68e-05	CbGpPWpGaD
Meloxicam—PTGS2—Metabolism—AKT1—type 2 diabetes mellitus	1.54e-06	2.47e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.53e-06	2.45e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.47e-06	2.35e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.47e-06	2.35e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.34e-06	2.15e-05	CbGpPWpGaD
Meloxicam—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	1.26e-06	2.01e-05	CbGpPWpGaD
Meloxicam—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.02e-06	1.64e-05	CbGpPWpGaD
Meloxicam—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	6.74e-07	1.08e-05	CbGpPWpGaD
